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Visualization of HIV-Associated Neurocognitive Disorders
ABSTRACT
It is widely known that human immunodeficiency virus type-1 (HIV-1) can cause
acquired immune deficiency syndrome (AIDS), but treatments to prevent the virus from
escalating to that severity have come a long way since the virus was first described in the 1980s.
The medications, combined antiretroviral therapy (cART), keep the virus from replicating, thus
stopping its progression to AIDS. However, this treatment does not seem to ultimately benefit
the brain, in part because cART does not uniformly penetrate the blood-brain barrier (BBB), and
in part because HIV-1 seems to permanently turn on the part of the immune system that causes
neuroinflammation. This allows the virus to exist in white blood cells and brain-resident glia
amongst the neurons, wreaking havoc on the body's central nervous system (CNS). Harris
Gelbard and his research laboratory aim to understand the molecules and pathways involved in
neuroinflammation caused by HIV-1 and the resulting HIV-associated neurocognitive disorders
(HAND). The lab's research has revealed several of the key components of this disease's
progression and has even synthesized small molecules with drug-like properties that confer
neuroprotection in models of HAND. Applications of these molecules in a pharmaceutical
setting and its delivery method for humans have yet to be established. The artwork created for
this Thesis will visualize some of the research through illustrations, an animation, and an
interactive game. The artwork will be effective in communicating the complexity of the research
with graphical representations due to the collaboration with and contributions from the members
of the Gelbard laboratory.
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INTRODUCTION
The debate continues as to whether or not viruses can be considered living organisms;
they have genetic material, but they lack organelles and the machinery to self-replicate. They can
spread from cell to cell, and the best medications only prevent the viruses from replicating. The
best advice doctors can give during an influenza virus infection is to 'wait it out'. How can
something that acts like it is alive, not be alive, and simultaneously cause so much destruction?
HIV, in particular, is a virus that has been in the United States since the 1980s and is still not
completely understood. The medications available keep the viral infection from progressing into
a much worse syndrome, but not from destroying the cells that they infect. The viruses' relentless
ability to reproduce and destroy the balance between the host’s immune and nervous systems,
even though it isn't a living organism, is still a mystery of nature.
The medical importance of this project stems directly from the work of Dr. Harris
Gelbard and the members of the Gelbard laboratory; their research aims to understand the
molecules and pathways involved in neuroinflammation caused by HIV-1 and the resulting HIVassociated neurocognitive disorders (HAND). The Thesis itself is a medium for the lab to
communicate their research to the public. The laboratory is very prolific in producing papers
explaining their research, but visual media that would translate some of their data would
definitely help summarize the information in a format that would be more available for public
consumption. Hopefully, raising awareness of this subject and educating other labs with the
current research will help the scientific community get closer to a cure. Neuroinflammation and
resulting neurocognitive disorders are what happen in the background of HIV 'suppression', so
answers must be found.
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WHAT IS HIV?
HIV, or human immunodeficiency virus, is a retrovirus that was first recognized in the
United States in 1981. Originally thought to only be sexually transmitted, evidence of HIV cases
became frequent in patients who were "intravenous drug users, blood transfusion recipients, and
infants born to infected mothers" (Porth, 428). Therefore, the virus could be spread by blood and
from mother to infant. Despite HIV's recent appearance, it has reached "epidemic proportions,
with around 33 million people infected worldwide" (Parham, 25), according to a 2007 figure by
the UNAIDS/World Health Organization. In 2007 in North America alone, there were 1.3
million HIV infected individuals (46,000 of those cases were new that year), and 21,000 deaths
(Parham, 25).
Protein synthesis in cells normally occurs in one direction: DNA is unzipped, a
complimentary RNA strand is created, and cellular machinery constructs a protein strand from
raw materials (amino acids) by following the RNA code. HIV is a retrovirus and, as the name
implies, directs its protein synthesis in a backwards (retro-) direction. After the lipid envelope of
the virus fuses with the host cell, the virus genome enters the host cell and a complimentary
strand of DNA is created. This new DNA integrates into the host cell's DNA and the process of
canonical protein synthesis occurs, but the end products are used to construct more viruses
(Parham, 352). When "infecting a human cell, HIV recruits 273 human proteins to serve its own
purpose" (Parham, 352).
The anatomy of the virus is more clever than it is original. The lipid envelope that
surrounds the virus is made of a few components. For starters, the lipids are stolen as the virus
buds from the host cell. Surface proteins on the lipid envelope include gp120 and gp41, where
the gp- is for glycoprotein. These markers are important for receptor binding and fusion with
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human cells; gp120 binds to CD4 on T-cells, which triggers the release of gp41, which helps the
envelope fuse with the host cell membrane. The nucleocapsid is within the lipid envelope and
surrounds the virus's RNA genome and proteins that direct the genome's transcription (Parham,
351). Although HIV-1 Tat protein is not included in the nucleocapsid, it is one of the first
proteins encoded from the original genome. The importance of HIV-1 Tat protein will be
explained later.
Once the virus enters an individual's body, the virus can devastate the immune system by
infecting and destroying immune cells; T cells (i.e. CDa lymphocytes) in particular. After the
initial infection period of two to six weeks, the patient enters a clinical latency period of up to
fifteen years. During the latency, or asymptomatic period, the virus continues its conquest over
the patient's immune system. As the immune system fails, opportunistic infections that are
normally held in check by host immune defenses become clinically evident put more stress on
the immune system. Together, the infections lower the T-cell count from an average >1000 Tcells/µL that left unchecked can drop to 0 T-cells/µL. When the number drops below 200 Tcells/µL, the patient has developed AIDS, or acquired immune deficiency syndrome (Parham,
354).
Even though there is no cure for the infection, there are means of controlling it "to slow
the progression [of the disease] to AIDS" (Porth 441). "The first drug that was approved by the
FDA for the treatment of HIV was zidovudine [an antiretroviral drug] in 1987" (Porth, 441).
Zidovudine is still prescribed to pregnant mothers to prevent the transmission of the virus to the
developing child (Parham, 358). However, instead of one medication being prescribed,
combination therapy is used to target a population of viruses that may differ from one another in
adult individuals. In general, combined antiretroviral therapy (cART) is the combination of

	
   8	
  

Visualization of HIV-Associated Neurocognitive Disorders
drugs that interfere with different stages of a virus’s replication cycle; the goal, in this case, is to
prevent the HIV infection from progressing to AIDS. "The goal of HAART [i.e. cART] is
sustained suppression of HIV replication, resulting in an undetectable viral load and increasing
[T] cell count" (Porth, 441). Unfortunately, the drugs and body's defenses can only slow down
the virus's progression, but not terminate it. "HIV and other retroviruses have high mutation rates
because their reverse transcriptases lack proofreading" (Parham, 357), thus increasing the chance
of a mutation to become resistant to drugs and immune system defenses. Despite the success that
an individual might be experiencing with the antiretroviral medications, penetration of the drug
through the blood-brain barrier is limited, leading to progression of neurologic disease in the
brain (Vetrivel, 44).

WHAT ARE NEUROCOGNITIVE DISORDERS?
In order to understand the implications of HIV infections in the brain, a brief description
of the cells involved is necessary. Cells of the central nervous system (CNS) are either neurons
or neuroglia. Important neuroglia involved in this discussion are astrocytes and microglia.
Aside from the many functions astrocytes have, for the purposes of this discussion, the only
relevant one noting is their role in the formation of the blood-brain barrier (BBB) (Sherwood,
137). Microglia are the resident immune cells of the brain; when they are in their ‘quiescent’
state (actually a misconception, since they constantly patrol neuronal synaptic architecture and
function), they extend projections between cells to monitor the area for antigens. Once an antigen
is detected, the microglia goes through a morphological change into an ameboid shape, rolls
towards the foreign substance, and destroys it (Sherwood, 138). "Microglia are derived from the
same bone-marrow tissue that gives rise to monocytes. During embryonic development,
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microglia migrate to the CNS, where they remain stationary [i.e. relative to their local microenvironment in a brain region] until activated by an infection" (Sherwood, 138). The important
leukocytes, or white blood cells, are T-cells and macrophages; both are attracted to the inflamed
brain when microglia release cytokines and enter as the BBB becomes more permeable.
HIV enters the brain by infecting infiltrating leukocytes. This Trojan horse approach
allows the virus to enter, without any interference from the blood-brain barrier. Once inside, the
virus is free to productively (i.e. make copies of itself) infect microglia and macrophages around
blood vessels, or perivascular macrophages and astrocytes (where the infection is restricted to
secretion of regulatory gene products like Tat). The virus does not infect neurons or other
specialized glia like oligodendrocytes, but the work here is focused on the unique set of
relationships between neurons, microglia, and macrophages.
Neurocognitive disorders occur because of an HIV infection in the brain. When
microglia come into contact with HIV, they become activated and destroy the infected cells, as
expected. Unfortunately, "excessive release of chemicals from overzealous microglia may
damage the neurons they are meant to protect" (Sherwood, 138). The disorder progresses when
microglia phagocytose not only damaged or dysfunctional synapses, but also normal synapses
between neurons in the brain. The loss of connections between neurons results in a loss of
communication and memory. This degenerative condition leads to the collection of disorders
called neurocognitive disorders.
"Even with stringent adherence to anti-retroviral therapy, >50% of patients living with
HIV-1 will develop HAND [HIV-associated neurocognitive disorders]" (Marker et al., 9998).
Resulting neurocognitive disorders from synapse destruction include:
•

HIV-1-associated dementia
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•

HIV-1-associated mild neurocognitive disorder

•

HIV-1 associated asymptomatic neurocognitive impairment

DR. HARRIS A. GELBARD’S RESEARCH
Dr. Harris Gelbard and his laboratory, in the Center for Neural Development and Disease
at the University of Rochester Medical Center, aim to understand the cellular and molecular
pathways that are involved in the pathophysiology of the disease. Gelbard and his laboratory
members use HIV-1 Tat [transactivator of transcription] protein to activate cells in the brains of
mice. "[The lab] elected to investigate the effects of acute hippocampal exposure to HIV-1 Tat
because a large body of literature using both rats and mice has demonstrated robust Tatassociated changes in synaptic architecture in this brain region as well as behavioral
consequences" (Lu et. al., 2).
Among the research being conducted to understand each molecule that plays a role in the
development of these HIV-associated pathologies, Gelbard and his laboratory have contributed
research to inventing a new drug that will function adjunctively with cART (combination
antiretroviral therapy). "Despite continued advances in combination antiretroviral therapy
(cART) that have turned human immunodeficiency virus-1 (HIV-1) infection into a medically
manageable disease, HIV-1-associated neurocognitive disorders (HAND) persist, prompting the
need for adjunctive therapy" (Marker et al., 9998). Their answer was URMC-099, a molecule
that inhibits the expression of MLK3 in neurons and immune cells of the central nervous system.
MLK3 is expressed when these cells become stressed, and in the context of HIV infection, marks
them for destruction by the immune system. In a research article published in 2013, the lab
reported that their "lead compound, URMC-099, robustly inhibits microglial release of
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inflammatory mediators and pathologic clearance of synaptic and axonal elements in in vitro and
in vivo models of HAND" (Marker et. al., 9999). URMC-099 was also able to reduce the
production of pro-inflammatory cytokines, thus reducing the chance of recruiting more immune
cells to the brain. However, "it did not normalize the cytokine production to control levels"
despite normalizing synaptic architecture (Marker et. al., 10010).
One piece of notable technology used in the Gelbard laboratory is the microfluidic
chamber. Experiments with the microfluidic chamber are the concept for the interactive game
developed as part of this Thesis project. The microfluidic chamber is a small, sterile, rectangular
polymer with four holes connected by two channels; a smaller channel connects the larger
channels. A solution of hippocampal neuronal cells from a rat are loaded in one side (2 wells) of
the chamber and those neurons are allowed three days to grow across the barrier into the
apposing wells. The empty wells are filled with a solution containing microglia and other
reagents and proteins; these include saline solution (as the control), URMC-099, and Tat protein.
This technology is useful in observing how different chemical environments affect the
relationship between microglia and neurons. It was this method that the laboratory used to
determine whether the URMC-099 molecule's "reduction in cytokine release and phagocytosis
would potentially have a neuroprotective effect" (Marker et. al., 10010).
An important piece of technology used by the laboratory for imaging their experiments
was the University of Rochester's two-photon fluorescence light microscope. "Two-photon
fluorescence microscopy allows three-dimensional imaging of biological specimens in vivo… it
offers the advantages of deeper tissue penetration and less photo damage" (So, 1). The photons
were important in exciting the fluorescence proteins of marked cells within the hippocampal
region of mice; green fluorescent protein (GFP) was expressed in microglia, and yellow
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fluorescent protein (YFP) was expressed in neurons. Some captured images were composited
into short micrograph animations (gifs), and later incorporated into the animation made for this
Thesis. With the use of two-photon fluorescent light microscopy, the lab was able to show how
"infiltrating inflammatory leukocytes engulfed dendritic spines and microglial processes" (Lu,
2). Another imaging technique used by the lab is immunocytochemistry, a technique where
marked antibodies specific to neuronal and microglial proteins are traced to detect their target
antigen.
This brief summary of Dr. Gelbard's research topics and techniques is still very dense and
extensive. There was definitely a need for art to help communicate their information and
interpret the micrographs from their observations. This Thesis represents a necessary relationship
between art and science.
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THE BODY OF WORK – OVERVIEW
The project includes an animation, an interactive game, and a series of illustrations that
accompany research papers, articles, grant proposals, and presentations for lectures and
conventions. The purpose of this project is to help interpret the research being conducted in the
Gelbard research lab to better communicate the pathophysiology and molecular targets that are
the mechanism for HAND. Most of the visuals previously being used to convey the information
were micrographs and crude illustrations. Even though micrographs are images of what is
literally taking place between cells, they are still small, difficult to interpret, and do not direct a
learner's attention to meet the desired instructional objective.

GOALS OF THE ARTWORK
The art created for this project have the following objectives:
•

Learners will be able to list the major steps involved in HIV protein's effect on
microglial activation and ultimate synapse engulfment

•

Learners will be able to identify molecules relevant to HIV infection, such as
cytokines released by immune cells and a particular HIV protein known as
transactivator of transcription, or Tat, studied by the lab

•

Learners will be able to compare and contrast various scenarios of 'normal' and
pathologic 'clinical' conditions

•

Learners will be able to actively learn about one of the lab techniques through use of
the game; topics covered include the cells studied, equipment involved, and
observations that are typically expected.
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ILLUSTRATION PROCESS
The illustrations all started in a similar fashion: with sketches and notes supplied by the
lab explaining their needs for a particular figure telling a story from their research. Afterwards, a
sketch of the actual figure was created and submitted to the lab members for review. Once a
critique of the illustration was received, edits were made and another draft was submitted. If all
aspects of the illustration were cleared, then the file was exported in a format suitable for the
illustration's final use. The important thing to notice is the amount of collaboration between all
members of the team: the illustrations, although not created by the lab, are reviewed by the lab to
maintain scientific accuracy.
Meetings were held at the University of Rochester to discuss their illustration requests.
During a typical meeting, as mentioned, sketches and notes were exchanged. Although the
sketches were very rough, in the sense that they were just generalized shapes of the desired
characters in the story being told, they were beneficial in seeing what the lab was expecting in
the illustrated figure. The meetings were also helpful because the science contained within the
story was explained. Sometimes additional printed lab materials were supplied to gain
background information on the topic, but most of the science being discussed was both building
on and pushing previously studied topics in human cellular biology, immunology, and pathology.
The supplemental printed materials included published papers from the Gelbard lab and
illustrated figures from other labs; the term illustrated is used lightly here because the simple,
colored, geometric shapes of the other labs' figures do not compare to the artwork submitted to
the Gelbard lab through this Thesis.
After meeting with the members of the Gelbard lab, a sketch summarizing everything
discussed was composited and submitted for review. There were a few cases where too much
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information needed to be crammed into a small illustration. One solution was to pick out the very
important information and build the illustration around it. The other solution was to avoid cutting
the amount of information and suggest two separate illustrations, each containing part of the
desired information. Other scenarios presented themselves where the illustration would be large
enough to contain all of the information the lab wanted to explain, but it would then be split into
two separate PowerPoint slides for easy interpretation during presentations.
When the artwork was handed over to the Gelbard lab for review, the scientific accuracy
of the images and labels were checked. Their critiques were usually sent via email, but
sometimes they were exchanged in person. The extent of the edits varied by project. The lab
members were very helpful in communicating their edits, both in person and over the internet.
Again, they generally critiqued the accuracy of the images and text. They did not mind the colors
chosen, as most were chosen based on medical illustration conventions. Colors for some of the
cells were chosen based on imaging techniques used by the lab; for example, microglia were
tagged with green fluorescent protein during experiments, so the cells were rendered as being
green in the illustrations.
Once the edits were made, a final draft was submitted for one final pass. If everything
about the illustration was deemed acceptable, then the file was exported based on its intended
use. It was important for the lab to communicate the intended use of the artwork prior to starting
so the file size and profiles could be properly set up (Image 01).
The research lab was very actively involved in the illustration process. Although this
body of work is a Thesis, it should be viewed more as a collaboration between all parties.
Without the contribution of the lab members' knowledge, the illustrations here would just be
strange visuals that lack substance.
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Published Illustrations:
Illustration for
LRRK2 Modulates Neuroinflammation and Neurodegeneration in Models of HIV-1 Associated
Neurocognitive Disorders, in the Journal of Neuroscience
Authors: Jenna M. Puccini, Daniel F. Marker, Timothy Fitzgerald, Justin Barbieri, Shao-Ming
Lu, Harris A. Gelbard
(Image 02)
This illustration was designed to show the simplified steps that lead to synapse
phagocytosis by microglia when in the presence of HIV-1 Tat protein. The steps show the
microglia morphological changes, antibody release, and the eventual synapse destruction; all
occurring within the central nervous system.
A reference image was supplied by the lab that they have used before explaining all of
the above steps. The only problem was that their image showed only one step: the final one. It
was concluded that this single image did not explain everything clearly and that a custom
illustration was necessary. A sketch was proposed, edited, and finally put into production.
Some colors were chosen arbitrarily, while others were already predetermined. Microglia
were colored green, for reasons mentioned earlier. However, the colors for the HIV-1 Tat protein
and antibodies were chosen to match the general color scheme of the rest of the illustration.
The illustration was organized in a hierarchy that was two-fold: one that showed the steps
from top to bottom, and another that was centered on large microglia in the center of the
illustration. The hierarchy of the steps is pretty obvious; the events would happen sequentially
down the marked path. The microglia in the center, although part of the path, has its own substeps associated with it to suggest that this is where a lot of the action takes place.
Micrographs from the lab's experiments helped show the nature of microglia extensions
and relative size between all of the cells being studied. The shape of various molecules used in
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the artwork was researched to ensure accuracy. Most molecules were found in the Protein Data
Bank; codes made available through the website were then used by UCSF Chimera to gain a 3dimensional representation of the molecule. A screenshot was captured in the program and
placed in Adobe Illustrator to be traced and filled. The style used to render the molecules was
inspired by David Goodsell of the The Scripps Research Institute and the RCSB PDB (Image
03).
Illustration for
PAF: Presynaptic and Postsynaptic Mechanisms of Injury in HAND
Co-sponsored by National Institutes of Mental Health and Allergy and Infectious Diseases
Author: Jennetta Hammond
(Image 04)
This illustration was created to visualize the proposed research that describes varying
concentrations of neurotransmitters in presynaptic neurons. Before this research, it was just
assumed that neurotransmitters were evenly distributed throughout the neuron or at least higher
in concentration closer to the synapse. The research suggests otherwise, that there are three
different areas of varying concentrations.
Again, the goal of the illustration was to show the different concentrations of
neurotransmitters in a neuron. This was achieved in two ways: one way was to represent the
vesicles as spheres dispersed throughout the neuron, and the other way are the bands of colors
overlap the neuron to clearly define each area. If this wasn't enough, each area was designated a
letter so it could be referred to in supporting text.
Initially, this illustration was meant to couple another one describing how vesicles are
moved from within the neuron to the active zone of the presynaptic neuron. It was suggested that
this was way too much information to cram into one illustration, and was later broken into the
two separate ones, although this illustration was the only one to be included in the grant proposal
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(Image 05).
The color of the neuron is based on standards in the medical illustration field, although
YFP (yellow fluorescent protein) is used in the lab’s microscopy studies to image the neurons.
The colors of the neurotransmitters were arbitrary, although cooler colors were chosen to make
them easily distinguishable under the layers of colors for the neuron and vesicles.
All of the illustrations created for the Thesis, whether they were made for print or just
PowerPoint presentation, were all approached the same way; with meetings to propose ideas and
gather references, submissions of sketches, reviews of the sketches, and final production. The
important thing to notice is the amount of collaboration between all members of the team: the
illustrations, although not created by the lab, are reviewed by the lab members to maintain
scientific accuracy.

ANIMATION PROCESS
The animation was approached in a methodical way: discussions were held to brainstorm
ideas, a script and storyboard were created to outline the story, models were created and
animated, and the animation was finally composited by adding titles, labels, and scene
transitions. Similar to the illustration process, the animation was created as a collaboration; the
art was created on one end, while the content was being fact-checked on the other. The animation
was created to help explain a concept in an entertaining medium, so maintaining scientific
accuracy was key.
The discussions were held at the University of Rochester in the lab, as well as online via
email. Email just made communicating faster and easier, so questions could be answered as they
arose and reference files could be shared. A brief description of what the animation was going to
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describe was sent for interpretation and reference. The description was brief and was left open
for much interpretation.
The reference materials sent via email were short gifs made from several micrographs
taken during observations. The composited images were made by a former lab member named
Jin Qi. The movies showed the general landscape of the brain at a cellular level: microglia and
neurons could be seen scattered around the outside of blood vessels. Monocytes were seen
rolling through the blood vessels, and only a few were caught passing through the thin
endothelial wall to encounter surrounding brain tissue. These videos were extremely helpful in
visualizing the relationship between all of the characters in the story being told.
A script was conceived from the brief summary initially sent and a storyboard was drawn
up along side of it. The script was written first to help set up scenes for the animation. Sketches
were made and the storyboard was laid out for review. The storyboard allowed the lab to put the
script into context and to get a feel for how the information would be communicated through this
medium; it was key to keep the images clear and simple enough for people to grasp the
information quickly if presented during conventions.
After the script and storyboard were reviewed and edits were made to both, a final review
of the material was conducted. Then models of the characters and environment were made in
Autodesk Maya, a 3D modeling and animating program. The animation was made using
Autodesk Maya, and later composited in Adobe After Effects so titles, labels, and sounds could
be added. The final file was exported and sent to the lab so they may use it. The animation was
also uploaded to Vimeo so the public may view it and to make the video more accessible for the
lab members (Image 06).
The animation was created with the help of the Gelbard research lab to maintain scientific
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accuracy. This project within the Thesis should also be considered a collaboration because of the
input from all members. With the lab member’s support, this animation becomes more than just a
mere visual, but rather a teaching tool.
Animation Decisions:
Several artistic decisions were made; such as color, lighting, and layout, but the layout
and flow of the scenes were collaborated on between all members of the thesis committee. Some
of the decisions were made using conventions in the medical illustration field. The animation
portion of the Thesis was a culmination of several software programs and techniques learned
through the program’s coursework.
Color was chosen based on each graphic element; certain aspects were kept muted to
direct the viewer’s attention to the main character being discussed. For example, the background
color was a muted neutral color so the vibrant colors of the characters would cause them to stand
out and catch the viewer’s attention. There was a molecule generated in Maxon Cinema 4D from
its code found online; colors were assigned to each element based on color conventions
established by chemists (Image 07). White blood cells were shown to be a hue between blue and
green to pay homage to their staining and fluorescent characteristics.
The toon-shader was primarily used in Autodesk Maya to render the 3-dimensional
characters, while the 2-dimensional art was made in Adobe Illustrator. This decision was made
to make the contrast between the 2-dimensional and 3-dimensional art a little less obvious. 2dimensional art was used to simplify some of the concepts discussed. The 3-dimensional art was
necessary in representing and interpreting micrographs supplied by the lab.
Some artistic license was used for lighting, and throughout the entire Thesis. As it is the
convention of medical illustrators, the main light came from the upper left corner of each scene.
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A 3-point lighting set-up was used to illuminate objects from all around, but the strength of each
light was adjusted to allow some areas to be darker to maintain the appearance of a 3dimensional shape. However, any light seen in micrographs comes from the activated fluorescent
proteins within the tagged cells.
Decisions about shapes were easy to make; micrographs from the lab and other resources
defined all of the shapes needed, so little interpretation was necessary. Micrographs taken
directly from the mice and other histology references helped in building the cellular and
environmental elements (Image 08). The molecular model came from information available on
the Protein Data Bank.
The dimension of the animation was kept small. The dimensions, 640 pixels wide by 480
pixels high, were chosen for easy placement within presentations. The smaller dimensions also
made the file size smaller. Together, this decision would not over burden the researchers’ files
when placing the animation into a presentation or referencing the Vimeo file online.
Most of the artistic decisions came from pre-existing methods for visualizing the cells
and their environments, while others were direct interpretations from other resources. Colors and
lighting were some of the attributes that have already been defined within the profession.
Specific shapes and details about cellular and molecular shapes were defined by very specific
resources; it was important to maintain these shapes to continue the goal of scientific accuracy
throughout the Thesis.

GAME CREATION PROCESS
The interactive piece of the Thesis was designed to be a teaching tool, in a game format
that was both engaging and easy to understand. In general, the area of their research, that this
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game covers, studies the specific interactions between microglia and neurons in different
chemical environments using the microfluidic chamber (Image 09). These experiments are
necessary for determining molecules, like URMC-099, that may be neuroprotective. The
microfluidic chamber was useful in isolating the cells in chambers, as the name suggests, and the
game design aimed at replicating this set-up. Instead of trying to imagine how these experiments
were conducted, this game was created to introduce the topic in an entertaining way.
The suggestion for an additional piece to add to the Thesis was last minute, but well
received. The primary investigator of the lab was very excited about the idea and only stated that
the game should be centered on the microfluidic chamber. Brainstorming began to occur almost
instantly and a new conversation about a microfluidic chamber game began. Another researcher
from the lab joined the conversation and supplied some specific information to include in the
game. One of the research papers read over the summer contained some of the information that
the original content was based on. Email exchanges occurred several times to critique the game
and maintain accuracy of the information discussed; mainly regarding the chemicals added to the
microglia chamber and effects of the chemical on the cells.
The game was created in Adobe Flash CC, and the artwork was created in Adobe
Illustrator. The version of Adobe Flash matters because this version allows the user to create
their file as an HTML5 canvas. In other words, instead of generating ActionScript as the
exported code, Flash would create an HTML5 and JavaScript document. This is important
because HTML5 and JavaScript are supported by many or all devices, unlike ActionScript.
Unfortunately, the HTML5 canvas is unable to perform all of the actions that ActionScript code
can, so this had to be put into consideration when planning the actual gameplay. Once the game
was completed and exported, it was hosted from my personal portfolio website for easy access.
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The lab was happy with this arrangement because they would not have to purchase a domain
name and a web hosting service for themselves.
Decisions about the Game Creation:
As with the other components of this body of work, most colors and shapes were
predetermined by medical illustration industry standards. However, imaging studies performed
by the lab influenced the colors. For example, microglia were represented as green cells because
of the presence of GFP.
The end result of the game was not the first design to be proposed. Although each design
was centered on the same concept of adding chemicals to a well in the chamber, the method of
doing so had varied. One idea involved simply pushing a button in a row of buttons, each with a
corresponding chemical mixture. Once pushed, a pipette would come down and inject the
mixture into the well. This idea was scrapped when comparing the actual sizes of the well and
pipette tip; the well is extremely small and the pipette tip would dominate the screen when the
injection occurs. A draft of the design with a smaller pipette tip was made, but quickly discarded
again due to its inaccuracy. (Image 10) The other half of the game, actually clicking on the cells
within the well, never changed.
It was decided to make the game have two levels, considering how much information
there was to cover. On the first page, the user sets up the cellular components of their wells. Text
on the side of the screen informed the user as to the actual cellular mixture used in the lab; this
was considered the first layer of information when discussing what is studied with a microfluidic
chamber. The action of setting up the wells was a simple drag-and-drop interactivity. This
method was perceived as more user engaging.
Drag-and-drop interactivity is fun, but the user might expect something else to happen
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once the item is dropped; typically, this is a small animation. The decision was made to simulate
how a fluid would spread when dropped into a container (Image 11). Shape tweens and clipping
masks were used in Adobe Flash to create this look on the first page.
The researchers stressed the importance of the growth period neurons are allowed
between being placed in the chamber well, and the time when the observations are made. Extra
animations would have been too costly on internet bandwidth, so this next layer of information
was presented in a panel that briefly discussed it. This panel, off screen in the Flash file, moves
onto the screen when the player moves from the first page to the second page, to suggest time
had passed between the two stages (Image 12).
Finally on the last page, the user can conclude the experiments by adding chemicals to
the well containing the microglia. Normally, the chemicals and microglia are already mixed
before being added to the well, but this may have been too much information at once for a user
just learning about this experiment method for the first time. Again, this game is a tool for
opening a discussion between labs in an interesting fashion. Chemicals were added using dragand-drop interactivity. The well contained a highlighted microglia that, when clicked on, would
present the user with a small panel that discussed how the added chemical would make the
microglia interact with a neuron (Image 13).
The style of the illustrations was kept simple because the information presented was so
dense. Although the illustration style was flat-vector, the game did not come across as being
immature; this was very important considering the audience that would potentially be using it.
Since there was a lot of information to discuss and only so much space to show it, the
presentation of the information had to be creative and well planned. The idea was to have large
images with bits of information that would be snuck into the game, so the user would not be
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turned off by the idea of learning.
The decisions made for this game were well planned and influenced by a lot of factors:
imagery standards of the medical illustration field, lots of information and ideas from the
researchers, and overall human-computer interaction concepts. Since this game presented so
much information, it was decided to break the game up into different layers, each concentrating
on different information. As with the rest of the Thesis, communication between everyone was
important in maintaining scientific accuracy of the game.
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CONCLUSION
This body of work was successful in many ways; not only did it achieve the goals that
were originally outlined in the beginning of this document, but it was also an invaluable learning
experience for someone entering the medical illustration profession. The time and effort put into
each project was definitely well spent, as the work was well received by the lab members and
knowledge of different computer programs was gained. Even though the amount of work
completed was fruitful, there are still opportunities to further the work.
The lessons learned include communicating with clients, reading and interpreting dense
research papers, and creating digital artwork for various outputs. Through communicating with
the client, the information from the research articles was broken down into key components that
would be important for creating illustrations. Communicating with the lab members included inperson meetings and email conversations; each exchange had to be concise in order to make the
most out of everyone’s time. Aside from learning much about the business and creation ends of
the field, it was a great education about the current state of HIV research, too.
It was apparent that the work had completed the original goals based on the lab’s positive
reception of each project. The lab members were pleased to see their worked visualized (on the
macroscopic level), and made good use of the illustrations by including them in their written
work. The publications include an article in the Journal of Neuroscience and grant proposal
(grant number: 1 F32 MH105288-01). An illustration was also used in a lecture on the lab’s
campus, and again at the Society of Neuroscience convention.
This work definitely has the potential to be continued further. More illustrations could be
made for the lab’s publications; when considering how prolific the lab’s members are at
generating publications, there must always be an opportunity to create the illustrations to
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accompany them. One animation is definitely not enough to summarize all that they do, too.
Unfortunately, time and financial constraints are always a factor and the potential abundance of
work will be cut short.
It was a great experience working with this lab; they are a great group of people that are
always open to explaining their work and who appreciate the amount of time and personal
research that goes into the artwork supplied to them. Both parties of this relationship benefited
from sharing their knowledge and talents, and the friendly, professional atmosphere made the
experience very enjoyable. It is sad to conclude this work, but this adventure is hopefully just the
start of more opportunities to create art that has a purpose in the scientific research and
healthcare communities.
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IMAGES
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GLOSSARY
Astrocyte - "a type of glial cell in the brain
major functions include holding the neurons in
proper spatial relationship, inducing the brain
capillaries to form tight junctions important in
the blood-brain barrier, and enhancing
synaptic activity" (Sherwood, G-2)
Blood-brain barrier (BBB) - "special
structural and functional features of the brain
capillaries that limit access of materials from
the blood into the brain tissue" (Sherwood, G3)
cART - combined antiretroviral therapy;
"antiviral therapy in which several antiviral
drugs are used together to try and avoid the
rapid generation of mutant viruses resistant to
one of the drugs alone" (Parham, G:6)
Dementia - "cognitive decline that can be
caused by any disorder that permanently
damages large areas of the cerebral
hemispheres or subcortical areas subserving
me more and learning" (Porth, 1378)

cognitive impairment with motor dysfunction
or behavioral/psychosocial symptoms
associated with HIV infection itself" (Porth,
436)
HIV - human immunodeficiency virus; "a
retrovirus that selectively attacks the CD4+
T-lymphocytes, the immune cells responsible
for orchestrating and coordinating the immune
response to infection" (Porth, 428)
Immunocytochemistry - "The study of cell
constituents by immunologic methods, such as
the use of fluorescent antibodies" (MedicalDictionary.theFreeDictionary.com)
In vitro - "outside the living body and in an
artificial environment" (MerriamWebster.com)
In vivo - "in the living body of a plant or
animal" (Merriam-Webster.com)

Epidemic - "outbreak of infectious disease
that affects many individuals within a
population" (Parham, G:8)

Kinase - "any of various enzymes that
catalyze the transfer of phosphate groups from
a high-energy phosphate-containing molecule
(as ATP) to a substrate" (MerriamWebster.com)

GFP - green fluorescent protein; marker of
gene expression and protein targeting in intact
cells and organisms

Leukocyte - "general term for a white blood
cell. Lymphocytes, granulocytes, and
monocytes are all leukocytes" (Parham, G:13)

Hippocampus - "the elongated, medial
portion of the temporal lobe that is a part of
the limbic system and is especially crucial for
forming long-term memories" (Sherwood, G7)

Microglia - "the type of glial cells that serve
as the immune defense cells of the CNS"
(Sherwood, G-9)

HAND - HIV-associated neurocognitive
disorder; condition defined by neurocognitive
damage inadvertently / indirectly caused by
HIV presence throughout the nervous system,
but primarily in the brain; "syndrome of

MLK3 - mixed-lineage kinase type 3, or
MAP3K11, "is expressed in neurons and CNS
immune effector cells and is activated by
cellular and metabolic stress" (Marker, 9999)
Monocyte - "type of white blood cell that
leaves the blood and sets up residence as a
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front-line defense agent in various tissues"
(Sherwood, 138).
Neurocognitive disorder - or
neurodegenerative disorder, "A chronic
progressive neuropathy characterized by
selective and generally symmetrical loss of
neurons in motor, sensory, or cognitive
systems" (MedicalDictionary.theFreeDictionary.com)
Neuroglia - or glial cells, cells within the
CNS that are not neurons (Sherwood, 135)
Neuroinflammation - inflammation of the
central nervous system
Neuroprotective effect - effect of a drug "to
interfere with the calcium cascade and thus
reduce brain cell injury" (Porth, 1302)
Opportunistic infection - "infections that
occur as the immune system becomes severely
compromised" and function is impaired; "they
are categorized by the type of organism
(fungal, protozoal, bacterial and

mycobacterial, viral)" (Porth, 433)
Retrovirus - "RNA virus that replicates via a
DNA intermediate that inserts into the host
cell chromosome" (Parham, G:18)
Synapse - "the specialized junction between
two neurons where an action potential in the
presynaptic neuron influences the membrane
potential of the postsynaptic neuron, typically
by releasing a chemical messenger that
diffuses across the small cleft between the
neurons" (Sherwood, G-14)
Tat - transactivator of transcriptase; HIV-1
protein that activates transcription of its
genome (Lu et al., 1)
URMC-099 - a new MLK3 inhibitor
molecule; research with this molecule
suggests that it may have neuroprotective
capabilities (Marker et. al., 9999)
YFP - yellow fluorescent protein; marker of
gene expression and protein targeting in intact
cells and organisms
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